Epidermal differentiation and stratification, crucial for barrier formation, are regulated by a complex interplay of transcription factors, including the evolutionarily conserved Grainyhead-like 3 (Grhl3/Get1); Grhl3-deleted mice exhibit impaired epidermal differentiation and decreased expression of multiple differentiation genes. To test whether Grhl3 regulates epidermal genes indirectly by controlling the expression of specific microRNAs (miRs), we performed miR profiling and identified 11 miRs that are differentially regulated in Grhl3 À / À skin, one of which is miR-21, previously shown to be upregulated in diseased skin, including in psoriasis and squamous cell skin cancer. We found that miR-21 is normally expressed in the post-mitotic suprabasal layers of the epidermis, overlapping with Grhl3. The miR-21 promoter is bound and repressed by Grhl3 indicating that these two factors are involved in a regulatory loop maintaining homeostasis in the epidermis. Although miR-21 overexpression in normal keratinocytes had mild effects on the expression of several known miR-21 targets, an enhanced downregulation of the miR-21 tumor-related targets, including MSH2, was observed in Ras-transformed keratinocytes. The increased sensitivity of transformed keratinocytes to miR-21's effects occurs in part through downregulation of the RNA-binding protein DND1 during the transformation process. Additionally, we observed increased tumorigenesis in mice subcutaneously injected with transformed keratinocytes lacking Grhl3. These findings indicate that decreased Grhl3 expression contributes to tumor progression and upregulation of the oncomir miR-21 in squamous cell carcinoma of the skin.
INTRODUCTION
The protective multilayered epidermis undergoes continuous renewal throughout the life of an organism. Its deepest layer, the basal cell layer, consists of proliferating progenitor cells that undergo a series of differentiation steps as they move towards the surface, forming first the spinous layer, then the granular layer, and finally the cornified layer before eventually sloughing off to make space for new cells. 1 Disruption of epidermal homeostasis is a prominent feature of many skin diseases, including skin cancer, the most common human malignancy. The homeostatic process is executed through a gene expression program controlled by a battery of transcription factors, including Grhl3, Klf4 and Trp63. 1 More recently, a class of novel regulators of mRNA expression called micro(mi)RNAs has been identified as another important source of regulation within this process. The initial recognition of the importance of miRNAs in skin came first from studies of the skin-specific knockouts of Dicer and DGCR8 in mice. [2] [3] [4] These mice show prominent neonatal lethality and pups that do survive show severe defects in both hair-follicle morphogenesis and epidermal differentiation. Later, the role of specific miRNAs was studied in the context of epidermal maintenance, including miR-203, 3, 5 miR-34a/c, 6 miR-200 and miR-205. [7] [8] [9] [10] Grainyhead-like 3 (Grhl3; also known as Get1), a transcription factor expressed in the differentiated suprabasal layers, has an important role in epidermal differentiation and barrier formation by regulating multiple genes important for executing the differentiation program in skin. 11, 12 These genes encode for structural proteins, lipid metabolizing enzymes and cell-cell adhesion molecules. Although we observed an enrichment of Grhl3-binding sites among the differentially expressed genes in the skin of Grhl3 À / À mice, 12 many lacked conserved Grhl3-binding sites in their proximal promoter, 12 prompting us to explore other mechanisms by which Grhl3 might regulate differentiation genes. We thus hypothesized that Grhl3 regulates some of its potential target genes indirectly by modulating expression of microRNAs. To that effect, we performed miRNA profiling experiments using total RNA from back skin of wild-type (WT) and Grhl3 À / À mice. Among the differentially expressed miRNAs we focused our research on miR-21, which is significantly upregulated miRNA in Grhl3 À / À skin. miR-21 is one of the most well studied microRNAs, partly because it is consistently upregulated in malignant cells; it was found to be upregulated in several cancers, including breast, lung, stomach, prostate, colon and pancreatic tumors. 13 miR-21 is abundantly expressed in skin, 2, [14] [15] [16] [17] and is upregulated in pathological conditions such as psoriasis, atopic dermatitis [18] [19] [20] and squamous cell carcinoma (SCC), 21 indicative of its potential importance in skin homeostasis. Therefore, it is intriguing that miR-21 is upregulated in Grhl3-deficient skin, which exhibits impaired differentiation and hyperplasia. In this study, we show that Grhl3 À / À keratinocytes display enhanced Ras-mediated tumorigenesis, and that downregulation of Grhl3 in transformed keratinocytes contributes to increased expression of miR-21. In addition, we demonstrate that the sensitivity of miR-21 targets is enhanced in transformed cells, possibly due to decreased expression of the RNA-binding protein DND1. Our studies reveal mechanisms that contribute to the overexpression of miR-21 in squamous cell carcinoma and enhanced sensitivity to miR-21 for its targets in malignant keratinocytes.
RESULTS
miRNA expression profiling identifies differentially expressed miRNAs in the skin of Grhl3 À / À mice To test the hypothesis that Grhl3 directly or indirectly regulates the expression of specific miRNAs in the skin, we globally profiled miRNA expression in the dorsal skin of wild-type (WT) and Grhl3
mice at embryonic day (e) 18.5. To decrease false positives, we performed two independent profiling experiments, using a paired approach where both sample types (WT and Grhl3 À / À ) were hybridized to the same chip, and a non-paired approach where the two sample types were hybridized to different chips with the same reference pool of RNA (Figure 1a) . Using a significance cutoff of Pp0.05, we identified 44 and 30 differentially expressed miRNAs in the paired and non-paired experiments, respectively (Supplementary Table 1 ). A total of 11 miRNAs, 6 downregulated and 5 upregulated, were identified in both experiments (Table 1) . We validated 8 of these differentially expressed miRNAs by quantitative PCR and found that 7 were altered in the same direction as observed in the miRNA profiling experiments (Table 1) . These experiments indicate that the loss of Grhl3 leads to alterations in the skin expression of several miRNAs, indicating a link between the transcriptional control of epidermal differentiation and miRNA expression.
Epidermal expression of miR-21 correlates with differentiation One of the microRNAs overexpressed in e18.5 Grhl3 À / À mouse skin was miR-21, a microRNA previously shown to be overexpressed in pathological skin, [19] [20] [21] prompting us to focus our study on the regulation and role of miR-21 in epidermal keratinocytes. We first measured mature miR-21 skin expression during mouse embryogenesis from e14.5 to e18.5, the time period corresponding to critical epidermal differentiation steps.
1 miR-21 is expressed highly throughout this period in WT mice and was significantly differentially regulated in Grhl3 À / À skin from e15.5 to e18.5 ( Figure 1b) correlating with the phenotypic appearance of defective epidermal differentiation in Grhl3 À / À mice. 12, 22 Upregulation of miR-21 in Grhl3 À / À skin was selective to the epidermis where Grhl3 is expressed (Figure 1c) . In-situ hybridization showed predominant miR-21 expression in the post-mitotic, differentiated suprabasal layers of the epidermis (Figure 1d , Supplementary Figure 1) , indicating that miR-21's spatial expression correlates with epidermal differentiation and Grhl3 expression in normal mouse skin. In addition, there is low but clear expression in hair follicles as well as diffuse, low-level expression in the basal layer and throughout the dermis. Together these data indicate that in normal epidermis, miR-21 expression correlates with differentiation. Intriguingly, in Grhl3-deleted skin, which exhibits impaired differentiation and a barrier defect, there is increased expression of miR-21, suggesting the possibility of a regulatory loop involving Grhl3 and miR-21 in the control of epidermal homeostasis.
Grhl3 binds to and represses the expression of the miR-21 promoter miR-21 upregulation in Grhl3 À / À mouse skin, as well as its overlapping expression with Grhl3 in the suprabasal layer of the epidermis, suggests that miR-21 could be a direct Grhl3 target. To test whether miR-21 is differentially regulated at a transcriptional level in the Grhl3 À / À mouse, we measured expression of its primary transcript (pri-miR21), precursor transcript (pre-miR21) and mature form (miR-21) in both WT and Grhl3 À / À mouse skin at e16.5. We observed an increase in all three forms of miR-21 in 
Grhl3
À / À mouse skin (Figure 2a ), suggesting regulation at the level of miR-21 gene transcription in Grhl3 À / À mice. As whole mouse skin was used to measure miR-21 expression, we sought to determine if this effect on miR-21 expression was cell autonomous. To test this possibility, we knocked down GRHL3 in cultured normal human keratinocytes (NHEK) by siRNA and induced differentiation with calcium for 2 days. We then performed quantitative real-time (RT)-PCR to measure miR-21 levels, which were significantly upregulated ( Figure 2b and Supplementary  Figure 2a) . Conversely we observed a reduction in miR-21 levels when Grhl3 was overexpressed in NHEK ( Figure 2c and Supplementaryl Figure 2b ). Consistent with these findings, Gene Set Enrichment Analysis 23, 24 on differentially expressed genes in GRHL3-knocked down NHEK, as determined by Affymetrix microarray analysis (Affymetrix, Santa Clara, CA, USA), revealed 'regulation by miR-21' as one of the overrepresented categories (Figure 2d ). Together, these results indicate that Grhl3 regulates miR-21 transcription in a cell autonomous manner in normal keratinocytes.
To test whether GRHL3 binds to the miR-21 promoter, we searched for GRHL3-binding sites using ConSite 25 and found several high-scoring sites in the promoter region of the human Mir-21 gene, located approximately 3.5 kb upstream of the mature miRNA sequence. 26 Using chromatin immunoprecipitation and quantitative PCR, there was enrichment of GRHL3 binding to the predicted site in the promoter region in NHEK, whereas no binding was observed to a region further upstream from the promoter (Figure 2e ). To test if the GRHL3-binding site is functional, we cloned B900 bp of the human miR-21 promoter region into a luciferase reporter plasmid and measured luciferase activity in presence of GRHL3 expression vector in HaCaT cells, which are immortalized human keratinocytes. Expression of GRHL3 mildly but significantly reduced miR-21 luciferase activity, and this repression was relieved by a non-binding 11 mutation of the GRHL3-binding site ( Figure 2f and Supplementary Figure 2c) . The above results indicate that GRHL3 directly binds to the miR-21 proximal promoter, reducing miR-21 expression in epidermal keratinocytes.
miR-21 appears dispensable for normal epidermal differentiation To investigate if knockdown of miR-21 affects normal epidermal differentiation, we took advantage of antagomirs, small RNA inhibitors that can be injected into mice. Locked Nucleic Acid (LNA)-modified antagomirs, 27, 28 either against miR-21 or scrambled, were injected subcutaneously in the upper dorsal region of newborn mice daily for 3 days. Despite a clear reduction in miR-21 levels in the skin of these mice (Figure 3a) , the histology of the injected dorsal skin appeared normal ( Figure 3b ) and there were no changes in expression of differentiation markers, Keratin 10 and Involucrin (Figure 3c ). Similarly, miR-21 antagomirs had no effect on keratinocyte proliferation as assessed by BrdU incorporation ( Figure 3d ). These experiments suggest that miR-21 does not have an important role in epidermal differentiation during normal homeostasis. The caveat is that we may not have achieved a complete epidermal knockdown of miR-21 in these experiments. However, these findings are strengthened by recent miR-21 mouse knockout studies, 29 which did not report epidermal abnormalities under normal homeostatic conditions. We therefore hypothesize that miR-21 has a more important role when skin homeostasis is perturbed. Consistent with this idea, miR-21 skin expression is highly upregulated after full thickness epidermal punch wounding (Supplementary Figure 2d) and after barrier disruption by wax depilation, which transiently induces epidermal hyperproliferation (data not shown).
Microarray expression analysis reveals potential targets of miR-21 in keratinocytes and increased target sensitivity in transformed keratinocytes In an attempt to tease out a miR-21 role and to identify the genes targeted by miR-21 in keratinocytes, we performed gene expression profiling experiments in NHEK transfected with premiR21, miR-21 antagomirs (Lna-21) and scrambled controls for both ( Figure 4a, Supplementary Figure 3) . Using a differential expression cutoff of 1.2-fold, we identified 1107 genes that were downregulated in pre-miR21-transfected cells and 1582 genes that were upregulated in Lna-21-transfected cells. Among these two gene sets, 249 genes were common, a significant enrichment (Pp0.0001; chi-squared test), indicating that these are likely miR-21 targets in human keratinocytes. To further increase the confidence in miR-21 target prediction, we overlapped this list with genes predicted to be miR-21 targets by miRNA target prediction programs Targetscan and PicTar, 30 thus reducing the list to 70 genes (Pp0.0001; chi-squared test) (Supplementary Table 2 ). DAVID 31 identified cell cycle as the most significantly enriched functional category by keyword in the list of 70 genes; there were also several genes in the list associated with DNA repair mechanisms. We then used quantitative RT-PCR to validate select genes of interest (CKAP2, E2F3), including previously described miR-21 targets (MSH2, CDK6, PDCD4, CDC25A), in HaCaT cells. Interestingly, we found only moderate transcript level changes in response to miR-21 overexpression or knockdown with some previously described targets showing no response (Figures 4b and c) .
A recent study found that when miR-21 is overexpressed in mice on a mutant Ras background the frequency of skin papillomas increased, and conversely when miR-21 is deleted on the mutant Ras background the skin papilloma frequency reduced Grhl3/Get1 suppresses miR-21 expression and tumorigenesis A Bhandari et al dramatically. 29 These findings, in conjunction with the facts that miR-21 does not appear to regulate normal skin homeostasis, and that its overexpression and knockdown causes only moderate gene expression changes in normal keratinocytes, suggest the possibility that miR-21 affects its targets more strikingly in transformed than normal keratinocytes. To test this hypothesis, we transformed HaCaT cells with Ras and SV40 vectors 32, 33 (Supplementary Figure 4a) . We confirmed the integration of the two transgenes into the genome by PCR and subsequent sequencing ( Supplementary Figures 4b and c) . Consistent with a pro-tumorigenic effect of these oncogenes, we observed a reduction in doubling time in the transformed HaCaT cells (data not shown) and tumor growth 3 weeks after they were injected into nude mice, whereas unmodified HaCaT cells failed to form tumors (Supplementary Figure 4d) . We measured mRNA expression levels of known and putative miR-21 targets in the transformed cells and observed a greater alteration in their expression with both overexpression (Figure 4d ) and knockdown of miR-21 ( Figure 4e ) with similar efficiency of transfection (Supplementary Figure 5) .
Transcripts encoding the DNA mismatch repair gene MSH2, loss of which is known to increase tumor predisposition of skin, 34, 35 were significantly down-and upregulated by pre-miR21 and Lna-21, in transformed keratinocytes. Consistent with this finding, MSH2 protein levels were decreased upon miR-21 expression (Figure 4f The RNA-binding protein DND1 modulates sensitivity to miR-21 actions The heightened sensitivity of miR-21 target mRNAs in transformed compared with unmodified HaCaT cells could be due to the differential expression of molecules capable of inhibiting miR-21 action. We therefore investigated the expression of transcripts for three known RNA-binding proteins (RBP), dead end homolog 1 (DND1), Embryonic lethal, abnormal vision, Drosophila-like (ELAVL) 1 and KH-type splicing regulatory protein (KHSRP) 1 in the two cell lines. These RNA-binding proteins are known to bind to the 3 0 UTRs of miRNA target genes, preventing miRNA binding and thus inhibiting their action. 36, 37 We observed reduced expression of DND1 mRNA but not of ELAVL or KHSRP in the transformed HaCaT cells (Figure 5a ), as well as loss of DND1 mRNA and protein in tumors from transformed HaCaT cells (Figure 5b and Supplementary Figures 7a and b) . Together, these findings raise the possibility that lower levels of DND1 might explain heightened sensitivity to miR-21 actions in transformed HaCaT cells and consistent with this idea, we found that expression of DND1 in transformed HaCaT cells could interfere with the miR-21-mediated repression of MSH2 (Figure 5c and Supplementary Figure 7c) . Conversely, when DND1 was knocked down in transformed HaCaT cells the transcript levels of MSH2 were reduced, and addition of miR-21 further enhanced this effect (Figure 5d and Supplementary  Figure 7d) . The 3 0 UTR of MSH2 contains a predicted DND1-binding site (Figure 5e ) 38 suggesting a direct interaction between DND1 protein and MSH2 mRNA. Consistently, an HA antibody pulled down MSH2 mRNA in extracts from HaCaT cells transfected with HA-DND1. This interaction is specific as IgG failed to precipitate MSH2 mRNA in these same cells, and HA antibody failed to precipitate MSH2 in non-transfected HaCaT cells. Furthermore, the HA antibody did not precipitate KLF4 mRNA from the transfected HaCaT cells (Figure 5f ). These data suggest that DND1 interacts directly with MSH2 RNA to alter its sensitivity to miR-21.
Grhl3 expression is decreased in mouse and human epidermal carcinomas To better understand the link between Grhl3 regulation of miR-21 and cancer, we studied the expression of Grhl3 in mouse papillomas and carcinomas derived from the two-stage DMBA/ TPA model of skin carcinogenesis by immunofluorescence (provided by Dr S Yuspa). Papillomas showed normal localization and clear expression of Grhl3, whereas a marked decrease in the expression of Grhl3 was observed in carcinomas, as well as a more diffuse appearance to its localization ( Figure 6A ). This was consistent with GRHL3 expression in human skin squamous cell carcinoma samples where GRHL3 expression was reduced or absent in all tumor samples; lowly expressed nuclear signal was detected in only 4 out of 60 tumors whereas strong nuclear expression was detected in 5 out of 5 normal skin samples ( Figure 6B and Supplementary Table 3 ). Together these data provide evidence for decreased Grhl3 expression in both mouse and human squamous cell skin cancers.
Grhl3-deleted keratinocytes show increased tumorigenesis in mice and miR-21 is highly upregulated in RAS-induced tumorigenesis To study the putative link between Grhl3 expression and tumor formation, we utilized RAS transformation of primary epidermal keratinocytes from WT and Grhl3 À / À mice in a xenograft mouse model. At 5 weeks post injection, Grhl3 À / À tumors were significantly larger than WT tumors (Figures 7a-c) . Although the tumors appear similar in histological composition, the knockout tumor shows increased cellular density (Figures 7d and e) . Consistent with decreased Grhl3 expression in mouse and human skin carcinomas (Figure 6 ), Grhl3 transcripts were decreased in tumors from Ras-transformed WT keratinocytes (Figure 7f ). Figure 8) . Consistent with our in vitro studies, Msh2 levels were significantly lower in Grhl3 À / À than WT tumors (Figures 7g-i) . Together, these data show that Ras transformation decreases Grhl3 levels and that Grhl3 acts to inhibit Ras-mediated epidermal keratinocyte tumorigenesis. Correlating with enhanced tumorigenesis in the absence of Grhl3 are increased miR-21 levels and decreased MSH2 levels.
DISCUSSION
The work in this study suggests a model (Figure 8 ) for how onocogenic mechanisms interact with the differentiation-promoting transcription factor Grhl3 to regulate epidermal tumorigenesis. We find that Grhl3 expression is decreased both in mouse and human squamous cell carcinomas of the skin (Figure 6 ). Furthermore, we show that Ras transformation of keratinocytes involves suppression of Grhl3 expression (Figure 7f ). Decreased expression of Grhl3 in keratinocytes contributes to upregulation of miR-21 levels (Figure 1 and Supplementary Figure 8 ) through direct transcriptional regulation of the miR-21 promoter (Figure 2 ). This regulation creates a positive feedback loop whereby increased miR-21 levels act to enhance the tumorigenic process through multiple mechanisms (Figure 8) . 39 In particular, we find that miR-21 targets the DNA repair gene MSH2 in keratinocytes as has been previously shown in breast cancer cells. 40 This process is further amplified through transformation-mediated downregulation of the RNA-binding protein DND1, 36 which leads to enhanced sensitivity of MSH2 transcripts to miR-21 interference ( Figure 5 ); DND1 binds directly to the 3 0 UTR of MSH2. Overall this model suggests mechanisms whereby epidermal tumorigenesis is driven by complex feed-forward loops involving downregulation of Grhl3 and upregulation of oncomir miR-21. Furthermore, our findings demonstrate that Grhl3 acts to suppress tumorigenesis independent of defective barrier formation or wound healing abnormalities, both of which have been linked to enhanced tumorigenesis in the DMBA/TPA model; a recent study found enhanced tumorigenesis in this model in Grhl3 À / À mice. 41 Our data in keratinocytes as well as in vivo suggests that miR-21 does not have an important role in normal epidermal differentiation ( Figure 3) . This is consistent with recent studies showing that miR-21 overexpression 29 and miR-21 KO mice 29, 42 were viable, fertile and had no apparent skin phenotype. Interestingly, when these miR-21 overexpressing mice were crossed with Ras-mutant mice, the frequency of skin papillomas increased, indicating the importance of miR-21 in pathological skin conditions like cancer. Furthermore, skin tumorigenesis was reduced in miR-21 knockout mice after Ras activation and in the chemical carcinogenesis model. 29, 42 Our results suggest that one mechanism underlying these effects of miR-21 on skin tumorigenesis is downregulation of tumor suppressors and DNA repair genes such as MSH2. In Table S2) , 17, 43 the predominant processes affected by miR-21 perturbation in keratinocytes.
Although we show that Grhl3 can directly suppress miR-21 expression, it is a mild repression suggesting that additional mechanisms are likely to contribute to miR-21 upregulation after transformation. In fact studies have also identified other factors including AP1 that can also drive up miR-21 in tumors, 44 and BMP4 as an inhibitor of miR-21 expression in keratinocytes. 17 Furthermore, miR-21 itself was recently shown to target Grhl3, 41 suggesting the possibility of a feed-forward autoregulatory loop between Grhl3 and miR-21.
Although our studies focused on tumorigenesis, similar mechanisms may underlie the pathogenesis of other skin diseases, such as psoriasis and atopic dermatitis, where miR-21 is upregulated. [18] [19] [20] In fact, during the epidermal wound response miR-21 appears to take on a pro-migratory role, promoting re-epithelialization 45, 46 and as miR-21 has been shown to also be regulated by Stat3 47 and Stat3-deficient mice show a defect in re-epithelization when wounded, 48, 49 a similar regulatory loop involving Stat3 may exist in epidermal wounding.
In conclusion, we show that the pro-differentiation regulator Grhl3 can affect tumorigenesis independent of defective barrier or wounding. As Grhl3 suppresses miR-21 expression in keratinocytes, decreased expression of Grhl3 during tumorigenesis contributes to increased expression of miR-21, which enhances the tumorigenic process by targeting several genes, including MSH2. In addition to the upregulation of miR-21 in tumors, miR-21 target sensitivity is enhanced in transformed cells, possibly due to reduced expression of the RNA-binding protein DND1.
MATERIALS AND METHODS miRNA profiling
The quality of the total RNA from mouse skin was verified on Agilent's 2100 Bioanalyzer (Agilent, Santa Clara, CA, USA). Total RNA was labeled with Hy3 or Hy5 fluorescent label, using the miRCURY LNA Array power labeling kit (Exiqon, Woburn, MA, USA). For the paired approach, KO was labeled with Hy3 and WT with Hy5, whereas in case of the non-paired approach, each WT and KO were labeled with Hy3, whereas the reference sample labeled by Hy5 was a pool of all RNAs combined. The Hy3-labeled samples and a Hy5-labeled reference RNA sample were mixed pair-wise and hybridized to the miRCURY LNA array version 11.0/12.0 (Exiqon), containing capture probes targeting all miRNAs registered in the miRBASE version 12.0. The hybridization and image analysis was performed by Exiqon. Quantified signals were background corrected and normalized using the global LOWESS (LOcally WEighted Scatterplot Smoothing) algorithm.
In-situ hybridization
In-situ hybridizations were performed using methods described previously. 50 miR-21 and control sense miR-159 probes (Exiqon) were DIG labeled and hybridized to paraformaldehyde fixed frozen skin sections at 461C. by site-directed mutagenesis (QuikChange Kit, Strategene, La Jolla, CA, USA). HaCaT cells were seeded 24 h before transfection. Luciferase reporter constructs with pcDNA3-Grhl3 (or control) were co-transfected by Lipofectamine 2000 (Invitrogen). Transfections were normalized to Renilla luciferase as described previously.
12 Keratinocytes were differentiated with 1.8 mM CaCl 2 for 2 days and luciferase activity was measured on the third day.
Western blot analysis 
Transformation of HaCaT cells
A total of 6 mg of pBabe-puro H-Ras V12 and pBabe-puro SV40LT (Addgene, Cambridge, MA, USA) were transfected separately and together into Phoenix Ampho cells (Orbigen, San Diego, CA, USA) using Lipofectamine. Media was changed 24 h after transfection and viral supernatant collected the next day. Virus was filtered (45 mM filter) and stored at À 80 1C. For infection, HaCaT cells were plated at B30% confluency in six-well plates. The viral infection cocktail was diluted 1/1200 in media with Polybrene (4 mg/ml). In all, 750 ng/ml puromycin (Mediatech, Manasaas, VA, USA) was added 24 h after infection (changed every 3 days) and cells were selected for 3 weeks. PCR Amplification was performed using Ras/SV40 primers (Supplementary Table S4 ) to verify insertion and products were sequenced to verify infection.
Quantitative RT-PCR for mRNA and miRNA
Total RNA was extracted using Trizol (Invitrogen). Complementary DNA was prepared using High Capacity cDNA kit (Applied Biosystems) and RT-PCR performed using Taqman or Sybr Green (Applied Biosystems) with CFX384 Real-Time PCR Detection System (Biorad Laboratories, Hercules, CA, USA). GAPDH and RPLP0 were used as endogenous controls for human cells and bactin for mouse. For miRNA expression, miRNA-specific complementary was made using TaqMan two-step miRNA assays (Applied Biosystems) according to the manufacturer's instructions. Sno202 was used as an internal control for mouse and RNU44 for human (Applied Biosystems).
Chromatin immunoprecipitation assays
For the chromatin immunoprecipitation assays, we followed previously described methods. 51 Antibody used was Grhl3 (Lifespan, Seattle, WA, USA, LS-C30200).
In-vivo inhibition of miR-21 using antagomirs
We used Exiqon's miRCURY LNA microRNA Power inhibitor for Lna-21 and a scrambled control (Lna-Scr). Probes had full phosphorothioate backbone and Locked nucleotide acid (Lna)-modified bases as described. 27 A total of 1, 5 or 10 mg/ml of the Lna-21 or Lna-Scr in phosphate-buffered saline was injected subcutaneously into the dorsal skin of newborn mice for 3 days and collected on day 4. To measure proliferation, pups were injected with 50 ug/g of 5-Bromo-2 0 -deoxyuridine (Brdu) (Sigma) 1 h before euthanasia. Grhl3/Get1 suppresses miR-21 expression and tumorigenesis A Bhandari et al
